Wiki source
Personalized RNA Medicine
A read-only view of this entry as wiki markup. This atlas is curated, so editing is disabled — but the source shows exactly how the page is structured.
# Personalized RNA Medicine Portal: Future Pharma Stage: Clinical platform Evidence: Clinical practice Template: Drug platform Risk: Moderate Reversibility: Reversible Last reviewed: Jun 2026 == Summary == Programmable RNA platforms can compress the path from molecular insight to tailored therapy, especially for rare or rapidly changing targets. == Key takeaways == * RNA medicines can add, silence, or redirect biological instructions without permanently editing DNA. * Delivery to the right tissue remains the central engineering challenge. * Personalization works best where the disease mechanism and target sequence are clear. == Platform map == Messenger RNA can instruct cells to make a protein. siRNA and antisense oligonucleotides can reduce expression of a harmful transcript. Other RNA systems can edit, splice, or regulate messages. The modularity of RNA makes it attractive for rare diseases, cancer vaccines, and rapid-response therapeutics. == Future role == RNA is likely to become one layer in a broader programmable-medicine stack. It can test hypotheses faster than permanent DNA editing and can be withdrawn if the risk-benefit profile changes. For longevity, RNA may matter less as a single anti-aging drug and more as a way to tune repair, immunity, metabolism, and tissue signaling. == Watchlist == * Extrahepatic delivery * Repeat dosing * Innate immune activation * Individualized manufacturing == References == * RNA therapeutic modalities — Programmable lipid nanoparticles for RNA therapeutics review, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12856183/. Use for mRNA, siRNA, ASO, and delivery-platform context. * LNP delivery systems — Lipid nanoparticles for RNA therapeutics review, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9691360/. Use for formulation, organ targeting, and delivery limitations. == Categories == [[Category:Future Pharma]] [[Category:mRNA]] [[Category:siRNA]] [[Category:antisense]]